Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

16.15
Delayed Data
As of May 25
 -0.30 / -1.82%
Today’s Change
7.02
Today|||52-Week Range
18.50
+33.47%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues473.0K6.6M478.0K0.00
 
 
 
 
Depreciation And Amortization402.0K398.0K400.0K411.0K
 
 
 
 
 
 
Operating ExpensesGross Income-------411.0K
 
 
General Expenses28.5M31.0M35.6M32.6M
 
 
 
 
 
Research And Development21.5M23.9M28.4M24.7M
 
 
 
 
 
Total Operating Expenses28.9M31.4M36.0M33.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.4M-24.8M-35.5M-33.0M
 
 
 
 
 
Other Expenses16.0K21.0K31.0K4.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.0M-24.3M-35.0M-32.5M
 
 
 
 
 
Net Income-28.0M-24.3M-35.0M-32.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.4M58.0M58.0M58.2M
 
 
 
 
 
Shares To Calculate EPS Diluted57.4M58.0M58.0M58.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$0.42-$0.60-$0.56
 
 
 
 
 
EPS Diluted-$0.49-$0.42-$0.60-$0.56